Grant: Emerging Team Grant: Regenerative Medicine and Nanomedicine - LOI

Although there have been great scientific advances in regenerative medicine (RM), the novelty of these therapies and the diverse socio-cultural response to RM have generated significant difficulties in translating these innovations from the lab to the clinic. The objectives of this project are twofold: (i) to increase our understanding of what factors encourage or hinder translation for RM; and (ii) to promote RM translation through widespread consultation with the global RM community. A multidisciplinary team of highly trained experts in ethics of new technologies, health law, stem cell regulations, intellectual property rights and science policy research will work together from across Canada to carry out research projects. Through collaboration, this team will combine their expertise to better align scientific, policy and regulatory efforts globally, thereby facilitate the translation process and increase the potential access and availability of regenerative medicine products and services.